Selective outcome reporting #skincancer. No benefit for patients w/ melanoma undergoing sentinel lymph node biopsy

This is an absolutely damning example of selective outcome reporting in NEJM https://t.co/bWD6zqRQDR

— ben goldacre, MBE LOL (@bengoldacre) March 23, 2016